UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Edoxaban population pharmacokinetics and exposure–response analysis in patients with non-valvular atrial fibrillation

European journal of clinical pharmacology, 2014-11, Vol.70 (11), p.1339-1351

2014

Volltextzugriff (PDF)

Population pharmacokinetic and exposure-response analysis of nilotinib in patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase

European journal of clinical pharmacology, 2012-05, Vol.68 (5), p.723-733

2012

Volltextzugriff (PDF)

OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine

Pharmacogenetics and genomics, 2008-07, Vol.18 (7), p.637-645

2008

Volltextzugriff (PDF)

Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease

Journal of the American College of Cardiology, 2019-07, Vol.74 (2), p.179-189

2019

Volltextzugriff (PDF)

Linking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 Trial

Circulation (New York, N.Y.), 2018-10, Vol.138 (18), p.1963-1973

2018

Volltextzugriff (PDF)

Nilotinib population pharmacokinetics and exposure-response analysis in patients with imatinib-resistant or -intolerant chronic myeloid leukemia

European journal of clinical pharmacology, 2013-04, Vol.69 (4), p.813-823

2013

Volltextzugriff (PDF)

Evaluating a physiologically based pharmacokinetic model for prediction of omeprazole clearance and assessing ethnic sensitivity in CYP2C19 metabolic pathway

European journal of clinical pharmacology, 2015-05, Vol.71 (5), p.617-624

2015

Volltextzugriff (PDF)

Population pharmacokinetic modeling and simulation for assessing renal impairment effect on the pharmacokinetics of mirogabalin

Journal of clinical pharmacology, 2016-02, Vol.56 (2), p.203-212

2016

Volltextzugriff (PDF)

Circulating trophoblast cell clusters for early detection of placenta accreta spectrum disorders

Nature communications, 2021-08, Vol.12 (1), p.4408-14, Article 4408

2021

Volltextzugriff (PDF)

Effect of Grapefruit Juice on the Pharmacokinetics of Nilotinib in Healthy Participants

Journal of clinical pharmacology, 2010-02, Vol.50 (2), p.188-194

2010

Volltextzugriff (PDF)

Effects of Rifampin and Ketoconazole on the Pharmacokinetics of Nilotinib in Healthy Participants

Journal of clinical pharmacology, 2011-01, Vol.51 (1), p.75-83

2011

Volltextzugriff (PDF)

Effect of the Proton Pump Inhibitor Esomeprazole on the Oral Absorption and Pharmacokinetics of Nilotinib

Journal of clinical pharmacology, 2010-08, Vol.50 (8), p.960-967

2010

Volltextzugriff (PDF)

Concurrent use of proton pump inhibitors or H2 blockers did not adversely affect nilotinib efficacy in patients with chronic myeloid leukemia

Cancer chemotherapy and pharmacology, 2012-08, Vol.70 (2), p.345-350

2012

Volltextzugriff (PDF)

Dose- and Time-Dependent Pharmacokinetics of Midostaurin in Patients With Diabetes Mellitus

Journal of clinical pharmacology, 2008-06, Vol.48 (6), p.763-775

2008

Volltextzugriff (PDF)

Discordant congenital heart defects in monochorionic twins: Risk factors and proposed pathophysiology

PloS one, 2021-05, Vol.16 (5), p.e0251160-e0251160

2021

Volltextzugriff (PDF)

Population Pharmacokinetics and Dose–Exposure Proportionality of Edoxaban in Healthy Volunteers

Clinical drug investigation, 2014-10, Vol.34 (10), p.743-752

2014

Volltextzugriff (PDF)

Pharmacokinetics and modeling of quercetin and metabolites

Pharmaceutical research, 2005-06, Vol.22 (6), p.892-901

2005

Volltextzugriff (PDF)

Uninterrupted administration of edoxaban vs vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation: Rationale and design of the ELIMINATE‐AF study

Clinical cardiology (Mahwah, N.J.), 2018-04, Vol.41 (4), p.440-449

2018

Volltextzugriff (PDF)

Effects of famotidine or an antacid preparation on the pharmacokinetics of nilotinib in healthy volunteers

Cancer chemotherapy and pharmacology, 2013, Vol.71 (1), p.219-226

2013

Volltextzugriff (PDF)

Lesbian, gay, bisexual, transgender content on reproductive endocrinology and infertility clinic websites

Fertility and sterility, 2017-07, Vol.108 (1), p.183-191

2017

Volltextzugriff (PDF)

Comparative In vitro cellular data alone are insufficient to predict clinical responses and guide the choice of BCR-ABL inhibitor for treating imatinib-resistant chronic myeloid leukemia

Journal of clinical oncology, 2010-04, Vol.28 (11), p.e169-e171

2010

Volltextzugriff (PDF)

Hysteroscopic polypectomy prior to infertility treatment: A cost analysis and systematic review

European journal of obstetrics & gynecology and reproductive biology, 2017-06, Vol.213, p.107-115

2017

Volltextzugriff (PDF)

A Mechanism-Based Population Pharmacokinetic Model for Characterizing Time-Dependent Pharmacokinetics of Midostaurin and its Metabolites in Human Subjects

Clinical pharmacokinetics, 2008-01, Vol.47 (12), p.807-816

2008

Volltextzugriff (PDF)

Effects of hepatic impairment on the pharmacokinetics of nilotinib: An open-label, single-dose, parallel-group study

Clinical therapeutics, 2009, Vol.31, p.2459-2469

2009

Volltextzugriff (PDF)

Effects of Yogurt and Applesauce on the Oral Bioavailability of Nilotinib in Healthy Volunteers

Journal of clinical pharmacology, 2011-11, Vol.51 (11), p.1580-1586

2011

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(100)
Buchkapitel
(7)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Edoxaban population pharmacokinetics and exposure–response analysis in patients with non-valvular atrial fibrillation

Population pharmacokinetic and exposure-response analysis of nilotinib in patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase

OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine

Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease

Linking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 Trial

Nilotinib population pharmacokinetics and exposure-response analysis in patients with imatinib-resistant or -intolerant chronic myeloid leukemia

Evaluating a physiologically based pharmacokinetic model for prediction of omeprazole clearance and assessing ethnic sensitivity in CYP2C19 metabolic pathway

Population pharmacokinetic modeling and simulation for assessing renal impairment effect on the pharmacokinetics of mirogabalin

Circulating trophoblast cell clusters for early detection of placenta accreta spectrum disorders

Effect of Grapefruit Juice on the Pharmacokinetics of Nilotinib in Healthy Participants

Effects of Rifampin and Ketoconazole on the Pharmacokinetics of Nilotinib in Healthy Participants

Effect of the Proton Pump Inhibitor Esomeprazole on the Oral Absorption and Pharmacokinetics of Nilotinib

Concurrent use of proton pump inhibitors or H2 blockers did not adversely affect nilotinib efficacy in patients with chronic myeloid leukemia

Dose- and Time-Dependent Pharmacokinetics of Midostaurin in Patients With Diabetes Mellitus

Discordant congenital heart defects in monochorionic twins: Risk factors and proposed pathophysiology

Population Pharmacokinetics and Dose–Exposure Proportionality of Edoxaban in Healthy Volunteers

Pharmacokinetics and modeling of quercetin and metabolites

Uninterrupted administration of edoxaban vs vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation: Rationale and design of the ELIMINATE‐AF study

Effects of famotidine or an antacid preparation on the pharmacokinetics of nilotinib in healthy volunteers

Lesbian, gay, bisexual, transgender content on reproductive endocrinology and infertility clinic websites

Comparative In vitro cellular data alone are insufficient to predict clinical responses and guide the choice of BCR-ABL inhibitor for treating imatinib-resistant chronic myeloid leukemia

Hysteroscopic polypectomy prior to infertility treatment: A cost analysis and systematic review

A Mechanism-Based Population Pharmacokinetic Model for Characterizing Time-Dependent Pharmacokinetics of Midostaurin and its Metabolites in Human Subjects

Effects of hepatic impairment on the pharmacokinetics of nilotinib: An open-label, single-dose, parallel-group study

Effects of Yogurt and Applesauce on the Oral Bioavailability of Nilotinib in Healthy Volunteers

Suchergebnisse filtern